← BMJ Neurology Open

Papers in BMJ Neurology Open

Page 4 · newest first

151. Communicating the risk of dementia: a scoping reviewBMJ Neurology Open · 2025
152. Pathophysiology of functional neurological disorder for the general neurologistBMJ Neurology Open · 2025
153. FAT1-weighted MRI-guided focused ultrasound thalamotomy for essential tremorBMJ Neurology Open · 2025
154. Treatment outcomes in functional neurological disorder: a systematic review and meta-analysis exploring the influence of symptom chronicityBMJ Neurology Open · 2025
155. Rationale and design of ‘StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack–the Randomized Controlled Trial’ (SAFEST-RCT)BMJ Neurology Open · 2025
156. Shared neural signatures in Functional Neurological Disorder and Chronic Pain: a multimodal narrative reviewBMJ Neurology Open · 2025
157. Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialBMJ Neurology Open · 2025
158. Relationship between brain atrophy and disability in a multi-site multiple sclerosis registryBMJ Neurology Open · 2025
159. Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteomeBMJ Neurology Open · 2025
160. Efficacy of intravenous thrombolysis in treating cortical and lacunar strokes: analysis from the Qatar Stroke Registry in a multi-ethnic populationBMJ Neurology Open · 2025
161. Evaluation and treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathyBMJ Neurology Open · 2025
162. Prognosis of people with focal epilepsy treated with anti-seizure medications (ASMs): a narrative review of current evidence and future directionsBMJ Neurology Open · 2025
163. Healthcare use before paediatric multiple sclerosis onset differs by age and sex: a nationwide cohort studyBMJ Neurology Open · 2025
164. Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisBMJ Neurology Open · 2025
165. Disease-modifying therapy during pregnancy and postpartum relapse activity in women with multiple sclerosis undergoing assisted reproductive technology treatment: a nationwide cohort studyBMJ Neurology Open · 2025
166. Macular OCT inner retinal changes reflect CNS involvement in m.3243A>G diseaseBMJ Neurology Open · 2025
167. Robotic thymectomy for ocular myasthenia gravis: a case series from a UK tertiary centreBMJ Neurology Open · 2025
168. Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: evidence from patient-reported outcomesBMJ Neurology Open · 2025
169. Cardiac involvement in anti-GABA-B receptor encephalitis: a case reportBMJ Neurology Open · 2025
170. Higher-level gait disorders: a population-based study on prevalence, quality of life, depression and confidence in gait and balanceBMJ Neurology Open · 2025
171. Gait and balance worsening after bilateral deep brain stimulation of the subthalamic nucleus (STN-DBS) for Parkinson’s disease: a systematic reviewBMJ Neurology Open · 2025
172. Impact of dual antiplatelet therapy on patients with minor stroke after thrombolysis: a systematic review and meta-analysisBMJ Neurology Open · 2025
173. Association between stroke and systemic inflammation response index (SIRI): a National Health and Nutrition Examination Survey (NHANES) Study 2015–2020BMJ Neurology Open · 2025
174. Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic reviewBMJ Neurology Open · 2025
175. Diagnostic process, misdiagnosis and bias in suspected idiopathic intracranial hypertension: a retrospective observational cohort studyBMJ Neurology Open · 2025
176. Volume contracted state, mortality and functional outcomes in patients with acute ischaemic stroke due to large vessel occlusionBMJ Neurology Open · 2025
177. Perfusion patterns as a tool for emergency stroke diagnosis: differentiating proximal and distal MCA occlusionsBMJ Neurology Open · 2025
178. Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disordersBMJ Neurology Open · 2025
179. Immunoglobulin unresponsive Guillain-Barré syndrome: rinse or repeat? A systematic reviewBMJ Neurology Open · 2025
180. CSF oligoclonal bands in neurological diseases besides CNS inflammatory demyelinating disordersBMJ Neurology Open · 2025
181. Creutzfeldt-Jakob disease mimicking limbic encephalitis as a cause of rapid neurological deteriorationBMJ Neurology Open · 2025
182. Unveiling neurophobia: exploring factors influencing medical students, residents and non-neurologist physicians globally and its implications on neurology care – a systematic review and meta-analysisBMJ Neurology Open · 2025
183. Time to endovascular thrombectomy for acute ischaemic stroke in language other than English (LOTE) communities in South-Western SydneyBMJ Neurology Open · 2025
184. Fundoscopy as a diagnostic biomarker in idiopathic normal pressure hydrocephalus: a pilot studyBMJ Neurology Open · 2025
185. Cognitive impairment in PSP compared with PD: assessment by clinical subtype and longitudinal changeBMJ Neurology Open · 2025
186. Qualitative systematic review on the lived experience of functional neurological disorderBMJ Neurology Open · 2025
187. Visual processing capacity and cognitive decline in Parkinson’s diseaseBMJ Neurology Open · 2025
188. Serum neurofilament light is superior to glial fibrillary acidic protein to distinguish sporadic frontotemporal dementia from late-onset primary psychiatric disorders: a retrospective DIPPA-FTD studyBMJ Neurology Open · 2025
189. Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosisBMJ Neurology Open · 2025
190. Long-read sequencing for diagnosis of genetic myopathiesBMJ Neurology Open · 2025
191. Reversible cerebral vasoconstriction syndrome in idiopathic multicentric Castleman disease under treatment with tocilizumabBMJ Neurology Open · 2025
192. Epidemiology and 10-year clinical care of juvenile myasthenia gravis in England: a retrospective cohort studyBMJ Neurology Open · 2025
193. Impact of LDL-C levels on severity and outcome of intracranial haemorrhage: a single-centre retrospective studyBMJ Neurology Open · 2025
194. Integrating clinical predictors and glial fibrillary acidic protein in prediction models for the prehospital identification of intracerebral haemorrhage in suspected strokeBMJ Neurology Open · 2025
195. Contemporary positive signs of functional limb weakness in post-acute sequelae of SARS-CoV-2: an exploratory analysis of their utility in diagnosis and follow-upBMJ Neurology Open · 2025
196. Spinal cord demyelination predicts neurological deterioration in patients with mild degenerative cervical myelopathyBMJ Neurology Open · 2025
197. Epidemiology and patient characteristics of the US myasthenia gravis population: real-world evidence from a large insurance claims databaseBMJ Neurology Open · 2025
198. Optimising early detection of degenerative cervical myelopathy: a systematic review of quantitative screening tools for primary careBMJ Neurology Open · 2025
199. Managing functional neurological disorder: treatment recommendations for health professionals in AustraliaBMJ Neurology Open · 2025
200. Diffusion tensor imaging in peroneal neuropathy: a prospective, single-centre studyBMJ Neurology Open · 2025